Mesenchymal stem cells (MSCs) are a source for cell-based
therapy. Although MSCs have the potential for tissue regeneration, their therapeutic efficacy is restricted by the uremic toxin,
p-cresol, in
chronic kidney disease (CKD). To address this issue, we investigated the effect of
fucoidan, a marine sulfated
polysaccharide, on cellular senescence in MSCs. After
p-cresol exposure, MSC senescence was induced, as indicated by an increase in cell size and a decrease in proliferation capacity. Treatment of senescent MSCs with
fucoidan significantly reversed this cellular senescence via regulation of SMP30 and p21, and increased proliferation through the regulation of cell cycle-associated
proteins (CDK2, CDK4,
cyclin D1, and
cyclin E). These effects were dependent on FAK-Akt-TWIST signal transduction. In particular,
fucoidan promoted the expression of cellular
prion protein (PrPC), which resulted in the maintenance of cell expansion capacity in
p-cresol-induced senescent MSCs. This protective effect of
fucoidan on senescence-mediated inhibition of proliferation was dependent on the TWIST-PrPC axis. In summary, this study shows that
fucoidan protects against
p-cresol-induced cellular senescence in MSCs through activation of the FAK-Akt-TWIST pathway and suggests that
fucoidan could be used in conjunction with functional MSC-based
therapies in the treatment of CKD.